Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL LA GRANDE PHARMACIE THIERS : revenue, balance sheet and financial ratios

SELARL LA GRANDE PHARMACIE THIERS is a French company founded 22 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LE HAVRE (76600), this company of category PME shows in 2025 a net income positive of 66 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL LA GRANDE PHARMACIE THIERS (SIREN 453747776)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 65 879 € 78 946 € -426 829 € 217 624 € 160 973 € 129 598 € 142 085 € 14 460 € 159 874 € 18 703 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL LA GRANDE PHARMACIE THIERS generates positive net income of 66 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 19 k€ -> 66 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

65 879 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 25%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 71%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

25.29%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

71.081%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

1.0%

Solvency indicators evolution
SELARL LA GRANDE PHARMACIE THIERS

Sector positioning

Debt ratio
25.29 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good -10 pts over 3 years

In 2025, the debt ratio of SELARL LA GRANDE PHARMACI... (25.29) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
71.08% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good +11 pts over 3 years

In 2025, the financial autonomy of SELARL LA GRANDE PHARMACI... (71.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 177.02. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

177.022

Liquidity indicators evolution
SELARL LA GRANDE PHARMACIE THIERS

Sector positioning

Liquidity ratio
177.02 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average -28 pts over 3 years

In 2025, the liquidity ratio of SELARL LA GRANDE PHARMACI... (177.02) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of SELARL LA GRANDE PHARMACIE THIERS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL LA GRANDE PHARMACIE THIERS is estimated at 1 046 495 € (range 710 156€ - 1 642 095€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
710k€ 1046k€ 1642k€
1 046 495 € Range: 710 156€ - 1 642 095€
NAF 5 année 2025

Valuation method used

Net Income Multiple
65 879 € × 15.9x = 1 046 496 €
Range: 710 157€ - 1 642 096€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL LA GRANDE PHARMACIE THIERS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL LA GRANDE PHARMACIE THIERS

What is the revenue of SELARL LA GRANDE PHARMACIE THIERS ?

The revenue of SELARL LA GRANDE PHARMACIE THIERS is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL LA GRANDE PHARMACIE THIERS profitable?

Yes, SELARL LA GRANDE PHARMACIE THIERS generated a net profit of 66 k€ in 2025.

Where is the headquarters of SELARL LA GRANDE PHARMACIE THIERS ?

The headquarters of SELARL LA GRANDE PHARMACIE THIERS is located in LE HAVRE (76600), in the department Seine-Maritime.

Where to find the tax return of SELARL LA GRANDE PHARMACIE THIERS ?

The tax return of SELARL LA GRANDE PHARMACIE THIERS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL LA GRANDE PHARMACIE THIERS operate?

SELARL LA GRANDE PHARMACIE THIERS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.